Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × NSCLC × Antigens × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Pemetrexed 2 Carboplatin 2 sulindac sulfone 1 pembrolizumab 1 nimotuzumab 1 aflutinib 1 Clinical Trials, Phase I as Topic 1 BID protein, human 1 Antigens 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04199559 2019-12-16

Evaluating Combination Therapy Using Autologous Dendritic Cells Pulsed With Antigen Peptides and Nivolumab for Subjects With Advanced Non-Small Cell Lung Cancer

Henan Cancer Hospital

Phase 1/2 Unknown

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡